AIM IMMUNOTECH INC. Litigation Settlement, Expense
AIM IMMUNOTECH INC. (AIM) reported Litigation Settlement, Expense of $1.22 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2021-03-31
- AIM IMMUNOTECH INC. litigation settlement, expense for the quarter ending 2019-12-31 was $1.48M.
- AIM IMMUNOTECH INC. litigation settlement, expense for the quarter ending 2019-09-30 was $0.00.
- AIM IMMUNOTECH INC. litigation settlement, expense for the quarter ending 2019-06-30 was -$260.00K.
- AIM IMMUNOTECH INC. litigation settlement, expense for the quarter ending 2018-12-31 was $0.00.
- AIM IMMUNOTECH INC. litigation settlement, expense for fiscal 2019 was $1.22M.
- AIM IMMUNOTECH INC. litigation settlement, expense for fiscal 2018 was -$474.00K.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 9 month as first filed | Litigation Settlement, Expense 12 month | Litigation Settlement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.48M derived: sum of 2 quarters · filed 2021-03-31 | $1.22M derived: sum of 3 quarters · filed 2021-03-31 | $1.22M 10-K · filed 2021-03-31 | -$1.22M 10-K · filed 2020-03-30 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$260.00K derived: sum of 2 quarters · filed 2020-11-12 | -$260.00K 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | -$260.00K 10-Q · filed 2020-08-14 | -$260.00K 10-Q · filed 2020-08-14 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | -$474.00K derived: sum of 3 quarters · filed 2020-03-30 | -$474.00K 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$474.00K derived: sum of 2 quarters · filed 2019-11-14 | -$474.00K 10-Q · filed 2019-11-14 | $474.00K 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | -$474.00K 10-Q · filed 2019-08-14 | -$474.00K 10-Q · filed 2019-08-14 | ||||
| 2016-09-30 | -$190.00K 10-Q · filed 2017-11-14 | -$1.63M derived: sum of 2 quarters · filed 2017-11-14 | -$1.63M 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | -$1.44M 10-Q · filed 2017-08-14 | -$1.44M 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |